Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano, Mohanraj Ramachandran, Anna Dimberg
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 9, pp. 1745-1770
Open Access | Times Cited: 1454

Showing 26-50 of 1454 citing articles:

The Role of HO-1 and Its Crosstalk with Oxidative Stress in Cancer Cell Survival
Shih-Kai Chiang, Shuen‐Ei Chen, Ling‐Chu Chang
Cells (2021) Vol. 10, Iss. 9, pp. 2401-2401
Open Access | Times Cited: 132
The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF
Seyedehdelaram Ghalehbandi, Jale Yüzügülen, Md Zahidul Islam Pranjol, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175586-175586
Open Access | Times Cited: 132
Hypoxia: The Cornerstone of Glioblastoma
Marta Domènech, Ainhoa Hernández, Andrea Plaja, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12608-12608
Open Access | Times Cited: 119
Interplay of oxidative stress, cellular communication and signaling pathways in cancer
Muhammad Javed Iqbal, Ayesha Kabeer, Zaighum Abbas, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 119
Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment
Ellen Scott, Angela M. Gocher, Creg J. Workman, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 116
Cancer Stem Cells—Key Players in Tumor Relapse
Monica Marzagalli, Fabrizio Fontana, M. Raimondi, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 376-376
Open Access | Times Cited: 115
Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
Revati Sharma, Elif Kadife, Mark A. Myers, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 114
New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis
Irina Larionova, Elena Kazakova, Tatiana S. Gerashchenko, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3253-3253
Open Access | Times Cited: 111
Chronic inflammation, cancer development and immunotherapy
Yalei Wen, Ying‐Jie Zhu, Caishi Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 99
Tumor-associated macrophages: an effective player of the tumor microenvironment
Udit Basak, Tania Sarkar, Sumon Mukherjee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 94
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain
Gennady G. Yegutkin, Detlev Boison
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 799-824
Open Access | Times Cited: 91
Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches
Nehad M. Ayoub, Sara K. Jaradat, Kamal M. Al-Shami, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 84
Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast
Vincent Geldhof, Laura de Rooij, Liliana Sokol, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 80
The role of miRNAs in liver diseases: Potential therapeutic and clinical applications
Ahmed S. Doghish, Mohammed S. Elballal, Ola Elazazy, et al.
Pathology - Research and Practice (2023) Vol. 243, pp. 154375-154375
Closed Access | Times Cited: 80
Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications
Jian-Wen Fang, Yue Lu, Jingyan Zheng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 78
Relationship between VEGF Family Members, Their Receptors and Cell Death in the Neoplastic Transformation of Colorectal Cancer
Dominika Dakowicz, Monika Zajkowska, Barbara Mroczko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3375-3375
Open Access | Times Cited: 76
Insights Into the Role of Matrix Metalloproteinases in Cancer and its Various Therapeutic Aspects: A Review
Sabeena Mustafa, Sheeja Koran, Lamya AlOmair
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 72
Cancer-associated fibroblasts: The chief architect in the tumor microenvironment
Mrinmoy Sarkar, Tristan Nguyen, Esheksha Gundre, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 67
miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay
Ahmed S. Doghish, Mohamed A. Ali, Salah S. Elyan, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154386-154386
Closed Access | Times Cited: 63
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 57
VEGF signaling: Role in angiogenesis and beyond
Pallab Shaw, Shailendra Kumar Dhar Dwivedi, Resham Bhattacharya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189079-189079
Closed Access | Times Cited: 57
Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
Fatemeh Davodabadi, Seyedeh Fatemeh Sajjadi, Mohammad Sarhadi, et al.
European Journal of Pharmacology (2023) Vol. 958, pp. 176013-176013
Closed Access | Times Cited: 56
Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways
Ahmed S. Doghish, Hesham A. El-Mahdy, Ahmed Ismail, et al.
Pathology - Research and Practice (2023) Vol. 243, pp. 154371-154371
Closed Access | Times Cited: 53
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 50
The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
César U. Monjarás-Ávila, Ana C. Lorenzo‐Leal, Ana C. Luque-Badillo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7946-7946
Open Access | Times Cited: 48

Scroll to top